Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieren A Marr

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|March 27, 2004
Antifungal therapy for febrile neutropenia: issues in clinical trial designKieren A Marr
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Aspergillus galactomannan index: a surrogate end point to assess outcome of therapy?Kieren A Marr
Expert Review of Anti-Infective Therapy|June 28, 2012
Cryptococcus gattii as an important fungal pathogen of western North AmericaKieren A Marr
Medical Mycology|April 17, 2008
Fungal infections in hematopoietic stem cell transplant recipientsKieren A Marr
Current Opinion in Infectious Diseases|April 20, 2002
The changing spectrum of candidemia in oncology patients: therapeutic implicationsKieren A. Marr
Oncology (Williston Park, N.Y.)|February 3, 2005
Invasive Candida infections: the changing epidemiologyKieren A Marr
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2011
Cryptococcus gattii: the tip of the icebergKieren A Marr
Current Opinion in Hematology|October 18, 2003
New approaches to invasive fungal infectionsKieren A Marr
The New England Journal of Medicine|January 25, 2002
Empirical antifungal therapy--new options, new tradeoffsKieren A Marr
The Journal of Clinical Investigation|November 21, 2019
The ownership paradox: nurturing continuity and change for the future ASCIKieren A Marr
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Current Opinion in Investigational Drugs (London, England : 2000)|March 27, 2004
Antifungal therapy for febrile neutropenia: issues in clinical trial designKieren A Marr
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Aspergillus galactomannan index: a surrogate end point to assess outcome of therapy?Kieren A Marr
Expert Review of Anti-Infective Therapy|June 28, 2012
Cryptococcus gattii as an important fungal pathogen of western North AmericaKieren A Marr
Medical Mycology|April 17, 2008
Fungal infections in hematopoietic stem cell transplant recipientsKieren A Marr
Current Opinion in Infectious Diseases|April 20, 2002
The changing spectrum of candidemia in oncology patients: therapeutic implicationsKieren A. Marr
Oncology (Williston Park, N.Y.)|February 3, 2005
Invasive Candida infections: the changing epidemiologyKieren A Marr
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2011
Cryptococcus gattii: the tip of the icebergKieren A Marr
Current Opinion in Hematology|October 18, 2003
New approaches to invasive fungal infectionsKieren A Marr
The New England Journal of Medicine|January 25, 2002
Empirical antifungal therapy--new options, new tradeoffsKieren A Marr
The Journal of Clinical Investigation|November 21, 2019
The ownership paradox: nurturing continuity and change for the future ASCIKieren A Marr
Pageof 19